BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34570443)

  • 21. Clinical outcomes of mammography in the National Breast and Cervical Cancer Early Detection Program, 2009-2012.
    White A; Miller J; Royalty J; Ryerson AB; Benard V; Helsel W; Kammerer W
    Cancer Causes Control; 2015 May; 26(5):723-32. PubMed ID: 25809209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the performance of three modalities of breast cancer screening within a combined programme targeting at-risk women in Indonesia: An implementation study.
    Choridah L; Icanervilia AV; Rengganis AA; At Thobari J; Postma MJ; D I van Asselt A
    Glob Public Health; 2023 Jan; 18(1):2284370. PubMed ID: 38015726
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and self breast examination remain important in the era of modern screening.
    Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
    Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Earlier detection of breast cancer by surveillance of women at familial risk.
    Tilanus-Linthorst MM; Bartels CC; Obdeijn AI; Oudkerk M
    Eur J Cancer; 2000 Mar; 36(4):514-9. PubMed ID: 10717529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial.
    Skaane P; Sebuødegård S; Bandos AI; Gur D; Østerås BH; Gullien R; Hofvind S
    Breast Cancer Res Treat; 2018 Jun; 169(3):489-496. PubMed ID: 29429017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological characteristics and long-term prognosis of screening detected non-palpable breast cancer by ultrasound in hospital-based Chinese population (2001-2014).
    Pan B; Yao R; Zhu QL; Wang CJ; You SS; Zhang J; Xu QQ; Cai F; Shi J; Zhou YD; Mao F; Lin Y; Guan JH; Shen SJ; Liang ZY; Jiang YX; Sun Q
    Oncotarget; 2016 Nov; 7(47):76840-76851. PubMed ID: 27689334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
    Cho N; Han W; Han BK; Bae MS; Ko ES; Nam SJ; Chae EY; Lee JW; Kim SH; Kang BJ; Song BJ; Kim EK; Moon HJ; Kim SI; Kim SM; Kang E; Choi Y; Kim HH; Moon WK
    JAMA Oncol; 2017 Nov; 3(11):1495-1502. PubMed ID: 28655029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women.
    Yen AM; Tsau HS; Fann JC; Chen SL; Chiu SY; Lee YC; Pan SL; Chiu HM; Kuo WH; Chang KJ; Wu YY; Chuang SL; Hsu CY; Chang DC; Koong SL; Wu CY; Chia SL; Chen MJ; Chen HH; Chiou ST
    JAMA Oncol; 2016 Jul; 2(7):915-21. PubMed ID: 27030951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
    Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
    Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
    Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
    Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women.
    Shen S; Zhou Y; Xu Y; Zhang B; Duan X; Huang R; Li B; Shi Y; Shao Z; Liao H; Jiang J; Shen N; Zhang J; Yu C; Jiang H; Li S; Han S; Ma J; Sun Q
    Br J Cancer; 2015 Mar; 112(6):998-1004. PubMed ID: 25668012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval.
    Prange A; Bokhof B; Polzer P; Tio J; Radke I; Heidinger O; Heindel W; Weigel S
    Rofo; 2019 Feb; 191(2):130-136. PubMed ID: 30103233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cost-effectiveness of multiple screening modalities on breast cancer in Chinese women from Shanghai].
    Wu F; Mo M; Qin XX; Fang H; Zhao GM; Liu GY; Chen YY; Cao ZG; Yan YJ; Lyu LL; Xu WH; Shao ZM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Dec; 38(12):1665-1671. PubMed ID: 29294584
    [No Abstract]   [Full Text] [Related]  

  • 37. Accuracy of clinical breast examination's abnormalities for breast cancer screening: cross-sectional study.
    Malmartel A; Tron A; Caulliez S
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():1-6. PubMed ID: 30974372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer.
    Aarts AMWM; Duffy SW; Geurts SME; Vulkan DP; Houssami N; Zappa M; Nagtegaal ID; Verbeek ALM; Broeders MJM
    Breast; 2019 Jun; 45():70-74. PubMed ID: 30884341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening MRI in Women With a Personal History of Breast Cancer.
    Lehman CD; Lee JM; DeMartini WB; Hippe DS; Rendi MH; Kalish G; Porter P; Gralow J; Partridge SC
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26744477
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.